Baxter International Inc.

Baxter International Inc. is a medical products company that employs over 64,000 people worldwide. Through its subsidiaries, it develops and provides a portfolio of healthcare products globally. It offers a range of products, including dialysis therapies and services, intravenous therapies, infusion pumps, remixed and oncology drug platforms, inhaled anesthesia and critical care products, parenteral nutrition therapies, biological products, medical devices, connected care solutions, integrated patient monitoring and diagnostic systems, and surgical video technologies.

Baxter’s products are used in a variety of medical settings, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and at-home patient care. The company sells its products through a direct sales force as well as independent distributors, drug wholesalers, and specialty pharmacies.

In addition to selling medical products, Baxter also provides contracted services to pharmaceutical and biopharmaceutical companies. It has a development agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules.

Founded in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois, and employs 64,000 people in over 100 countries. It is highly committed to innovation and advancing healthcare excellence, and continuously seeks to improve patient care through technological advancements and collaborations. In 2019, Baxter was recognized for its efforts as it was named one of the World’s Most Ethical Companies for the sixth year in a row. Also, in 2019, the company achieved a 37% reduction in year-over-year emissions from its global operations.